15th INTERNATIONAL CONGRESS OF PARKINSON'S

Abstracts by Topic
720 Putaminal diffusivity in 1.5T MR imaging for the differential
diagnosis of neurodegenerative parkinsonism
A. Hussl, R. Esterhammer, M. Schocke, G.K. Wenning, W. Poewe,
K. Seppi (Innsbruck, Austria)
721 Enhanced catecholamine transporter binding in the locus coeruleus
of patients with early Parkinson’s disease
I.U. Isaias, G. Marotta, G. Pezzoli, O. Sabri, J. Schwarz, P. Cavallari,
J. Classen, P. Crenna (Milano, Italy)
722 Usefulness of transcranial sonography to improve diagnosis of
tremor and parkinsonism in early stages of disease
L. Ispierto, D. Vilas, P. Latorre, A. Dávalos, R. Álvarez (Badalona,
Barcelona, Spain)
723 Factors influencing the relative risk of DAT deficit in the PARS study
cohort
D. Jennings, A. Siderowf, M. Stern, S. Eberly, D. Oakes, K. Marek,
PARS Investigators (New Haven, Connecticut, USA)
724 Development of a glutamate mGluR5 receptor imaging agent in
Parkinson and Huntington’s disease
D. Jennings, J. Seibyl, O. Barret, G. Tamagnan, J. Batis, D. Alagille,
S. Lee, G. Zubal, D. Russell, K. Marek (New Haven, Connecticut, USA)
726 Altered functional organization of the motor system related to ankle
movements in Parkinson’s disease – Insights from functional MRI
P. Katschnig, P. Schwingenschuh, M. Jehna, M. Svehlík, K. Petrovic,
S. Ropele, E.B. Zwick, E. Ott, F. Fazekas, R. Schmidt, C. Enzinger
(Graz, Austria)
727 7T MRI shows 3D structural abnormalities of the substantia nigra in
Parkinson’s disease
J.-M. Kim, E.S. Oh, B.-S. Jeon, D.-H. Kwon, S.-H. Oh, Z.-H. Cho,
H.-J. Jeong, S.-Y. Park, Y.-B. Kim, J.-G. Chi (Seongnam, Korea)
728 Clinical correlation of neuroimaging in diagnosis of extra pyramidal
disorders
S. Kushwaha, P. Singh, S. Sharma (Delhi, India)
729 [18F]FP-CIT PET and [18F]FDG PET findings in PD patients with
impulse control disorder
Y. Kim, J.-S. Kim, S.-J. Kim, S.-R. Kim, J. Kim, S. You, C.S. Lee (Seoul,
Korea)
730 Temporal discrimination threshold correlates with the degree of
nigrostriatal dopaminergic dysfunction and axial motor deficits in
Parkinson’s disease
C.H. Lyoo, M.J. Lee, Y.H. Ryu, M.S. Lee (Seoul, Korea)
731 Management of wearing-off with entacapone in PD: An f-MRI study
N. Tambasco, E. Luchetti, A. Castrioto, V. Rossi, S. Caproni, E. Marsili,
P. Floridi, P. Chiarini, E. Sacchini, I. Silvestri, A. Gallina, P. Calabresi,
A. Rossi (Perugia, Italy)
732 Prospective observations of brain ischemic lesions and plasma
homocysteine level in Parkinson’s disease
T. Maeda, K. Nagata, T. Yamazaki, D. Takano, H. Komatsu,
M. Watanabe (Akita, Japan)
733 Structural changes in the sensorimotor pathway and correlations
with clinical score in essential tremor
L. Marais, C. Gallea, T. Popa, S. Meunier, S. Lehéricy, M. Vidailhet
(Paris Cedex 13, France)
15 th INTERNATIONAL CONGRESS OF PARKINSON’S
DISEASE AND MOVEMENT DISORDERS
734 The neurochemical profile of writer’s cramp and its changes after
non-invasive cortical stimulation: A 3 Tesla magnetic resonance
spectroscopy study
S. Meunier, M. Marjanska, R. Valabregue, T. Popa, Y. Worbe, M. Russo,
E. Auerbach, D. Grabli, C. Bonnet, M. Vidailhet, S. Lehericy (Paris,
France)
735 Hemichorea as the onset of unkwown type 2 diabetes mellitus
B.V. Mihaela, Z. Julie, G. Sophie, R. Mathieu, Z. Mathieu (Paris,
France)
736 Diagnostic [123I]FP-CIT SPECT grading at baseline is correlated
with motor severity at 36 months in patients with Parkinson’s disease
T. Nissen, E.J. Newman, J. Patterson, D.M. Hadley, K.A. Grosset,
D.G. Grosset (Glasgow, United Kingdom)
737 Prefrontal cortex is hypoactive in left- but not right-side most
affected de novo Parkinson’s disease
P.J. Planetta, A. Kurani, J. Prodoehl, D.M. Corcos, C.L. Comella,
D.E. Vaillancourt (Chicago, Illinois, USA)
738 Development of a 3D-transcranial sonography method for detecting
Parkinson’s disease (PD) – A pilot study
A. Plate, A. Ahmadi, T. Klein, O. Pauly, N. Navab, K. Boetzel (Munich,
Germany)
739 Neural atrophy associated to impulse control disorders (ICDs) in
Parkinson’s disease: A voxel based morphometry (VBM) study
M. Plebani, R. Biundo, P. Formento-Dojot, L. Bernardi, L. Ghezzo,
L. Foscolo, F. Meneghello, A. Venneri, A. Antonini (Venice, Italy)
740 Abnormal cerebello-cortical connectivity in essential tremor is
corrected by non invasive repeated stimulation of the cerebellum
T. Popa, C. Gallea, L. Marais, E. Roze, M. Vidailhet, S. Lehericy,
S. Meunier (Paris, France)
741 Dopamine modulation of the default mode network in patients with
Parkinson’s disease
I. Rektorova, L. Krajcovicova, R. Marecek, M. Mikl (Brno, Czech
Republic)
742 Brain tissue echogenicity – Implications for substantia nigra studies
in parkinsonian patients
K. Sadowski, K. Szlachta, M. Serafin- Król, J. Galazka- Friedman,
A. Friedman (Warsaw, Poland)
743 Structural and iron content changes in basal ganglia of
presymptomatic Huntington’s disease subjects: A multimodal
approach
C. Sanchez-Castaneda, A. Cherubini, F. De Gregorio, P. Peran,
S. Orobello, U. Sabatini, F. Squitieri (Rome, Italy)
744 Comparison of memory recall in parkinsonian patients: An FMRI
study
M. Saxena, S.S. Kumaran, V. Goyal, M. Behari (New Delhi, Delhi,
India)
745 Iron accumulation in the brain of patients with Parkinson’s disease
D. Simmons, S. Barnes, M. Zarifi, A. Obenaus, R. Pender, M. Liu,
M. Haacke, K. Dashtipour (Loma Linda, California, USA)
746 Association of olfactory dysfunction and brain metabolism in
Parkinson’s disease
T. Baba, A. Takeda, A. Kikuchi, T. Hasegawa, N. Sugeno, Y. Nishio,
Y. Hosokai, K. Hirayama, E. Mori (Sendai, Miyagi, Japan)
TORONTO
111
June 5–9, 2011 Toronto, ON, C anada
Abstracts
by topic